XOMA Royalty Corporation Common Stock
Market Cap
520M
Short interest (May 15)
6.3%
Net Short (Jun 03 ): 0.1%
Borrow Fee
0.26%
↓ 23.2%
Available Shares
400K
↓ 7.3%
Price Chart
Company Overview
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.